SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$119,854
-54.3%
116,363
-48.5%
0.01%
-20.0%
Q2 2023$262,046
-30.7%
225,902
-9.8%
0.01%
+11.1%
Q1 2023$378,128
-41.8%
250,416
-3.6%
0.01%
-18.2%
Q4 2022$649,453
+432.3%
259,781
+1850.5%
0.01%
+266.7%
Q4 2021$122,000
-91.2%
13,319
-89.8%
0.00%
-88.5%
Q3 2021$1,390,000
+65.7%
130,047
+140.4%
0.03%
+73.3%
Q2 2021$839,00054,0880.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders